Skip to main content
Clinical Trials/NCT03507504
NCT03507504
Unknown
N/A

REspectful CAring for the AGitated Elderly. How to Best Meet the Needs of People With Dementia With Severe Behavioural Disturbances. Toward a Respectful and Cost-effective Model

Fondazione Europea di Ricerca Biomedica Ferb Onlus12 sites in 7 countries500 target enrollmentApril 19, 2018
ConditionsDementia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dementia
Sponsor
Fondazione Europea di Ricerca Biomedica Ferb Onlus
Enrollment
500
Locations
12
Primary Endpoint
change of BPSD
Last Updated
6 years ago

Overview

Brief Summary

The treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) continue to raise difficult problems. Both the pharmacologic and non-pharmacologic therapies often fail to achieve the expected results. The aim of this study is to assess the short- and long-term efficacy of an intervention, the Special Care Unit for patients with BPSD (SCU-B), already implemented in some countries but not validated so far, as well as its cost-effectiveness

Detailed Description

Two cohorts of 250 patients each will be recruited by six clinical centres endowed with a SCU-B (one cohort) and six centres lacking this structure. The follow-up will last 3 years, during which patients will be visited every 6 months and submitted to a battery exploring the severity of the BPSD and the quality of life. All adverse events will be registered, as well as some anticipated occurrences (admissions to the general hospital for intercurrent diseases, admissions to a SCU-B pertaining to the clinical participating centre and, if any, admissions to a SCU-B not pertaining to the Consortium member, nursing home placement). At the same time the quality of life of the primary caregivers will be measured, as well as their attitude toward dementia. A cost-effectiveness analysis will be performed comparing the cohorts. Finally the time to the nursing home placement will be recorded and compared between the two cohorts

Registry
clinicaltrials.gov
Start Date
April 19, 2018
End Date
December 31, 2021
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Carlo Alberto Defanti

Study Coordinator

Fondazione Europea di Ricerca Biomedica Ferb Onlus

Eligibility Criteria

Inclusion Criteria

  • diagnosis of primary dementia (DSM IV)
  • MMSE score ≤ 24
  • NPI global score ≥ 32/144
  • a caregiver (informal/family member or formal caregiver) who commits her/himself to accompany the patient along the three-year course of the study
  • living at home (nursing home residents are excluded).

Exclusion Criteria

  • presence of uncontrolled medical disease potentially contributing to the cognitive decline and BPSD
  • concomitant psychiatric disorders or chronic alcoholism
  • concomitant diseases severe enough to reduce life expectancy \< 6 months

Outcomes

Primary Outcomes

change of BPSD

Time Frame: baseline, 6, 12, 18, 24, 30, 36 months

Neuropsychiatric Inventory (NPI), range 0-144

Secondary Outcomes

  • quality of life of patients(baseline, 6, 12,18, 24, 30, 36 months)
  • quality of life of caregivers(baseline, 6, 12, 18, 24, 30, 36 months)
  • cost-effectiveness of SCU-B(baseline, 6, 12, 18, 24, 30, 36 months)

Study Sites (12)

Loading locations...

Similar Trials